Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Equity Ratio: 2012-2025

Historic Equity Ratio for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to 0.23.

  • Enanta Pharmaceuticals' Equity Ratio fell 32.59% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 32.59%. This contributed to the annual value of 0.23 for FY2025, which is 32.59% down from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Equity Ratio is 0.23, which was down 12.47% from 0.26 recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Equity Ratio high stood at 0.93 for Q1 2021, and its period low was 0.23 during Q3 2025.
  • Moreover, its 3-year median value for Equity Ratio was 0.37 (2024), whereas its average is 0.40.
  • Data for Enanta Pharmaceuticals' Equity Ratio shows a maximum YoY crashed of 51.32% (in 2024) over the last 5 years.
  • Enanta Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.87 in 2021, then dropped by 0.78% to 0.87 in 2022, then tumbled by 48.27% to 0.45 in 2023, then dropped by 28.38% to 0.32 in 2024, then slumped by 32.59% to 0.23 in 2025.
  • Its Equity Ratio stands at 0.23 for Q3 2025, versus 0.26 for Q2 2025 and 0.29 for Q1 2025.